US FDA Plans Rare Disease Center Of Excellence, But Not "That" Kind Of COE

 
• By Derrick Gingery
  
Business person standing in the middle of a circular maze with red arrow
After the OND reorganization, the rare disease program will continue helping assessors as needed. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet